Technical

Technical — The Price Picture

Price action is telling a different story than the narrative of funded runway and a first commercial milestone implies. QS sits a third below its 200-day average, has been cut roughly in half over six months, and its trend regime flipped back to negative in February. Yet near-term momentum has just turned bullish, realized volatility is at the low end of its own history, and the stock is still up nearly double over twelve months off a washout low. The read: a bounce is underway inside a larger downtrend, with $6 and $9 as the gates.

Price snapshot

Last Close (USD)

$7.31

YTD Return

-33.9%

1-Year Return

92.4%

52-Week Range Position

23.2%

Beta (5Y)

2.56

The stock closed at $7.31 on 2026-04-22. That is 23% of the way between the $3.75 52-week low and the $19.07 52-week high — closer to the floor than the ceiling. YTD is down roughly a third; yet the one-year print is still strongly positive because the base (spring 2025) was a multi-year capitulation low. Beta of 2.6 means every 1% SPY move has historically translated into a 2.6% QS move, which is why this name is a factor-sensitive trade, not a diversifier.

Full-history price with 50 and 200-day SMA

A fresh death cross (50-day SMA falling below 200-day SMA) printed on 2026-02-23. This is the fifth such regime flip since 2022 — QS has never sustained a golden-cross regime for long. Price at $7.31 sits about 30% below the 200-day average of $10.43.

The long arc is unmistakable: a late-2020 SPAC euphoria peak above $130, a three-year grind down to the $3.75 washout in April 2025, a spring-summer 2025 rally that pierced $19, and a seven-month retracement that gave back most of it. The regime label today is downtrend, confirmed by price under 200-day and the February death cross. The 50-day ($6.90) is still below the 200-day ($10.43), meaning there is no moving-average support overhead; resistance ladders up from current price.

Relative strength vs SPY

The rebase tells the real story. Over three years SPY has roughly compounded to 170; QS has gone on a round-trip and ended near 94 — down 6% while the market nearly doubled. On a relative basis QS has underperformed SPY by about 75 percentage points over three years, and the gap has only widened since the summer 2025 local top. Relative strength is deeply negative and has not yet turned.

Momentum — RSI and MACD

RSI closed at 59 — neutral-to-constructive, not overbought. The MACD histogram flipped positive in mid-April after a long negative stretch, and the MACD line just crossed above signal. Both indicators agree that near-term momentum (1 to 3 months) has turned up. This is a classic oversold-bounce pattern inside a downtrend: the trend-following 200-day still points down, but the faster oscillators have reset.

Volume and conviction

No Results

Every one of the top three volume spikes was an up day — and in each case the stock moved up more than 27% on volume over 12 times average. That pattern — heavy conviction only on upside gaps — is typical of heavily shorted, catalyst-driven small caps where squeezes dominate tape and sellers are patient. Recent 12-month average daily volume sits near 10-20 million shares with periodic 100M+ blowouts on news.

Volatility regime

Realized 30-day vol is 54% — below the 5-year median of 77% and near the 20th percentile. For QS, this is quiet. Historical bands top out above 300% (the 2021 meme-vol spike) and the p80 band is 112%. The compression matters: volatility expansion tends to follow contraction, so from here a directional move is more likely than continued range-bound chop. Combined with the bullish momentum flip, the asymmetry currently tilts slightly upward — but this is a small-cap post-SPAC, so regime changes and gap risk are material.

Technical scorecard and stance

No Results

**Stance: neutral with a bearish skew, 3-6 month horizon.** The near-term momentum flip is real and could carry price to the $9.00 confluence (50-day trend shelf and gap-fill from late February). But the larger structure — death cross, price under 200-day, three-year relative underperformance — keeps the dominant trend down. **Upside trigger: a sustained close above $9.00** would nullify the February death-cross regime and open a path toward $11-12. **Downside trigger: a break of $6.00** (recent pivot and round-number support) would re-open a test of the $3.75 52-week low and likely all-time-low zone near $3.40. The stock is compressed, catalyst-sensitive, and borrow-cost driven — position size accordingly.